Replies to post #41993 on Humanigen Inc (fka HGENQ)

[cowtown jay]

Is the Sanofi spin-off of their healthcare division designed to partner with Humanigen on the asthma market, and more?

According to Humanigen's Featured Presentation, "...historical clinical results could provide basis for global partnering discussions."

asthma mentioned on five slides in the chart deck

https://ir.humanigen.com/English/events-and-presentations/default.aspx

Does Sanofi think that lenz could do better than their Regeneron partner, using Dupixent? Or is Sanofi looking to expand their supply chain?

https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-fda-approved-first-and-only-treatment